Drug Trial Radar · NCT00334386
Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.
Last checked: Nov 20, 2026Latest source record: Mar 6, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
388
Actual
Start
Apr 2005
Primary completion
Not stated
Study completion Feb 2006
Sponsor
- Lead sponsor
- Ferrer Internacional S.A.Industry
- Sponsor type
- Industry
- First posted
- Jun 7, 2006
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary objective:To demonstrate the no-inferiority in efficacy of treatment with Torsemide-PR in relation to Torsemide-IR in patients with mild and/or moderate hypertension. Secondary objectives: To evaluate the safety and tolerability of Torsemide-PR.
Conditions
- Hypertension
Interventions
Torasemide Prolonged Release (loop diuretic)Drug
Torasemide Immediate Release (loop diuretic)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Difference in mm Hg between the mean diastolic blood pressure (DBP) values the baseline period and the values at the end of the treatment period.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.